Bart Meuris | Cardiac Devices and Implants | Innovative Research Award

Innovative Research Award

Bart Meuris
University Hospitals Leuven, Belgium

Bart Meuris
Affiliation University Hospitals Leuven
Country Belgium
Scopus ID 6602378855
Documents 208
Citations 7,574
h-index 37
Subject Area Cardiac Devices and Implants
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9176-293X

Bart Meuris is a Belgian cardiovascular researcher, cardiac surgeon, and academic leader associated with University Hospitals Leuven and the Department of Cardiovascular Sciences. His scholarly work focuses on cardiac surgery, heart valve technologies, transcatheter interventions, cardiovascular biomaterials, and mechanical circulatory support systems. Through an extensive publication portfolio and sustained contributions to cardiovascular innovation, Meuris has played a significant role in advancing clinical and translational research within the field of cardiac devices and implants.[1]

Abstract

Bart Meuris has established a distinguished academic record in cardiovascular medicine through research addressing heart valve replacement, transcatheter therapies, surgical innovation, thrombosis prevention, and device performance evaluation. His work integrates engineering principles with clinical practice to improve patient outcomes in structural heart disease. With more than two hundred indexed publications and thousands of citations, his research demonstrates substantial influence within contemporary cardiovascular science.[1]

Keywords

Cardiac Surgery, Heart Valve Replacement, Transcatheter Aortic Valve Implantation, Cardiovascular Devices, Valve Durability, Mechanical Valve Thrombosis, Cardiovascular Innovation, Structural Heart Disease.

Introduction

The development of safer and more durable cardiovascular devices remains a major priority in modern medicine. Bart Meuris has contributed to this objective through investigations of surgical and transcatheter valve technologies, device-related complications, and long-term cardiovascular outcomes. His work reflects a multidisciplinary approach that combines clinical evidence, biomedical engineering, and translational research to address complex cardiovascular challenges.[2]

Research Profile

As Chair within the Department of Cardiovascular Sciences at Universitair Ziekenhuis Leuven, Meuris has maintained active involvement in research concerning prosthetic heart valves, cardiovascular surgery, hemodynamics, and implant performance assessment. His scholarly output spans clinical studies, registry analyses, experimental investigations, and collaborative international projects. The breadth of his publication record reflects sustained engagement with emerging cardiovascular technologies and evidence-based treatment strategies.[3]

Research Contributions

  • Investigated Factor XI inhibition strategies for preventing mechanical valve thrombosis in experimental models.[4]
  • Evaluated sex-related outcomes following sutureless aortic valve replacement using registry-based evidence.[5]
  • Examined the current status and future development of rapid deployment valve technologies.[6]
  • Studied durability and hemodynamic performance of transcatheter valves used in aortic stenosis treatment.[7]

Publications

Recent publications authored or co-authored by Meuris include studies on Factor XI inhibition for mechanical valve thrombosis prevention, sex-related outcomes following Perceval Plus valve replacement, rapid deployment valve technologies, transcatheter valve durability, and cerebrovascular complications following transcatheter aortic valve implantation. These works collectively address clinical efficacy, procedural safety, and long-term device performance.[4][7]

Research Impact

The measurable influence of Meuris’s research is reflected by an h-index of 37, more than 7,500 citations, and a substantial body of peer-reviewed publications. His investigations have contributed to understanding cardiovascular device performance, surgical outcomes, and thrombosis prevention strategies, supporting evidence-based advancements in cardiovascular medicine and cardiac surgery.[1]

Award Suitability

Bart Meuris demonstrates qualifications aligned with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine. His sustained publication record, leadership within cardiovascular sciences, and contributions to cardiac device innovation illustrate a commitment to advancing clinical research and improving cardiovascular healthcare delivery. The scope and impact of his work support consideration for recognition under the Innovative Research Award category.

Conclusion

Through extensive research in heart valve technologies, cardiovascular implants, and surgical innovation, Bart Meuris has contributed meaningful knowledge to the field of cardiovascular medicine. His combination of academic leadership, scientific productivity, and translational research impact positions him as a notable contributor to contemporary cardiac science and device development.

References

  1. Elsevier. (n.d.). Scopus author details: Bart Meuris, Author ID 6602378855. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602378855
  2. ORCID. (n.d.). Bart Meuris Research Profile.
    https://orcid.org/0000-0001-9176-293X
  3. Universitair Ziekenhuis Leuven. (2024). Department of Cardiovascular Sciences Employment Record.
  4. Meuris, B. et al. (2026). Factor XI inhibition with gruticibart prevents mechanical valve thrombosis in a porcine pulmonary model.
    DOI: https://doi.org/10.1016/j.bvth.2026.100168
  5. Meuris, B. et al. (2026). Sex-related outcome after sutureless aortic valve replacement with Perceval Plus.
    DOI: https://doi.org/10.1093/icvts/ivag170
  6. Meuris, B. et al. (2026). Rapid deployment valves: current position on the market and future directions.
    DOI: https://doi.org/10.1080/17434440.2026.2638363
  7. Meuris, B. et al. (2026). Hemodynamic performance and durability of transcatheter valves for native aortic valve stenosis.
    DOI: https://doi.org/10.1080/00015385.2025.2576449

Hajime Kataoka | Heart Failure | Best Researcher Award

Dr. Hajime Kataoka | Heart Failure | Best Researcher Award

Nishida Hospital | Japan

Dr. Hajime Kataoka is a distinguished Cardiologist and Physician-Scientist at Nishida Hospital, Oita, Japan, widely recognized for his pioneering contributions to cardiovascular medicine. He has devoted his career to advancing the understanding, diagnosis, and treatment of cardiovascular diseases, with particular expertise in clinical electrocardiography and heart failure. His research focuses on body fluid status and cardio-renal interactions in patients with heart failure, exploring how electrolyte balance influences cardiac function and disease progression. Dr. Kataoka is best known for developing the groundbreaking “chloride theory” of heart failure pathophysiology, which redefines traditional perspectives by emphasizing chloride’s key role in regulating body fluid distribution and congestion, surpassing the conventional sodium-based understanding. This innovative theory has significantly influenced modern approaches to assessing diuretic response, predicting prognosis, and optimizing treatment strategies in heart failure management. With 107 published documents, 1,101 citations from 816 citing documents, and an h-index of 19, Dr. Kataoka has made a lasting impact on cardiovascular research and clinical practice. His scientific insights continue to inspire new investigations into electrolyte physiology, fluid regulation, and therapeutic innovation, solidifying his reputation as a thought leader in contemporary cardiology and as a driving force behind transformative advances in the field.

Profiles: Scopus | Orcid

Featured Publications

Kataoka, H. (2023). Acetazolamide as a potent chloride-regaining diuretic: Time to re-evaluate its diverse actions. Polish Archives of Internal Medicine.

Kataoka, H. (2022). Estimation of plasma renin activity on the basis of serum and urinary chloride concentrations versus sodium concentrations. Cardiorenal Medicine.

Kataoka, H. (2022). Mechanistic insights into chloride-related heart failure progression according to the plasma volume status. ESC Heart Failure.

Kataoka, H. (2020). Comparison of changes in plasma volume and renal function between acetazolamide and conventional diuretics: Understanding the mechanical differences according to their effects. Cardiology.

Kataoka, H., & Yoshida, Y. (2020). Enhancement of the serum chloride concentration by administration of sodium-glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: A pilot study. Diabetology & Metabolic Syndrome.

Yaodong Li | Electrophysiology | Best Researcher Award

Prof. Yaodong Li | Electrophysiology | Best Researcher Award

Prof. Yaodong Li, Department of Pacing and Electrophysiology, the First Affiliated Hospital of Xinjiang Medical University, China

Prof. Yaodong Li is a leading expert in cardiac electrophysiology at the First Affiliated Hospital of Xinjiang Medical University, China. He holds a Doctor of Medicine in Cardiology from Xinjiang Medical University and serves as Professor and Chief Physician at the Cardiovascular Disease Center. Renowned for his work in pacing and atrial fibrillation, he has received numerous national and regional awards for scientific and clinical innovation. With several projects funded by the National Natural Science Foundation of China, Prof. Li is recognized as a “Research-oriented Talent” and continues to advance cardiovascular medicine through research, clinical excellence, and education.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Prof. Yaodong Li embarked on his medical journey at Xinjiang Medical University, where he pursued a Doctor of Medicine in Cardiology from September 2008 to July 2012 in Urumqi, Xinjiang. His foundational years in this esteemed institution laid the groundwork for a career deeply rooted in cardiovascular research and clinical excellence. During his academic training, he quickly distinguished himself through rigorous study and early contributions to scientific research.

📚 PROFESSIONAL ENDEAVORS:

Since August 2018, Prof. Li has served as a Professor and Chief Physician at the Cardiovascular Disease Center of Xinjiang Medical University. His professional journey reflects an upward trajectory marked by commitment to patient care, cutting-edge electrophysiological techniques, and leadership in academic medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ELECTROPHYSIOLOGY:

Prof. Li’s core expertise lies in cardiac electrophysiology, pacing, and atrial fibrillation management. He has been actively involved in national and regional scientific research projects, showcasing a strong focus on innovative treatment modalities and clinical electrophysiological advancements. His research is widely respected for its clinical relevance and technical innovation.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s work has earned him numerous awards and honors, demonstrating his prominence within the national and regional cardiology communities:

  • 2008–2023: Multiple Scientific and Technological Progress Awards from Urumqi City and Xinjiang Autonomous Region

  • 2012: Awarded for Excellent Paper at the 10th National Academic Biannual Meeting of the Chinese Society of Electrophysiology and Pacing

  • 2013 & 2014: Second Prize at the Xinjiang Natural Science Awards (Ranked 2nd)

  • 2022: Recognized with the “Elite in Atrial Fibrillation Prevention and Treatment” Clinical Technology Innovation Honor

  • 2023: Swept honors at the 14th Pacing Summit Forum including:

    • First Prize for Excellent ICD Case

    • Second Prize for Leadless Excellent Case

    • Excellent Young Physician Award

🔎 ACADEMIC CITES AND RECOGNITION:

His studies have contributed significantly to Chinese cardiovascular literature, often cited in national medical conferences and publications. His rankings in award listings reflect not only quality research but also peer acknowledgment of his impact on clinical practice and knowledge dissemination.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Yaodong Li represents the future of electrophysiology in China—a visionary in device therapy, pacing technologies, and clinical research leadership. As a “Research-oriented Talent” honored by the Chinese Research Hospital Association in 2024, he is set to:

  • Inspire a new generation of electrophysiologists

  • Spearhead multicenter research projects on atrial fibrillation and ICD innovations

  • Promote global collaborations in cardiac rhythm management

🌍CONCLUSION:

Prof. Yaodong Li stands as a distinguished figure in the field of cardiac electrophysiology, blending clinical expertise with groundbreaking research and innovation. His dedication to advancing pacing techniques and atrial fibrillation treatment has earned him national recognition, prestigious awards, and significant research funding. As a mentor, physician, and scientist, he continues to shape the future of cardiovascular care in China and beyond. With a passion for excellence and a commitment to improving patient outcomes, Prof. Li remains a true pioneer and inspiration in the world of cardiology.

TOP NOTABLE PUBLICATIONS

Title: MAPK14/AIFM2 pathway regulates mitophagy-dependent apoptosis to improve atrial fibrillation
Authors: Wang, Lu; Sang, Wanyue; Jian, Yi; …; Tang, Baopeng; Li, Yaodong
Journal: Journal of Molecular and Cellular Cardiology
Year: 2025

Title: The impact of frailty on the prognosis of chronic heart failure patients treated with cardiac resynchronization therapy defibrillator implantation
Authors: Gao, Liang; Lyu, Huasheng; Tang, Baopeng; …; Zukela, Tuerhong; Lu, Yanmei
Journal: Zhonghua Nei Ke Za Zhi (Chinese Journal of Internal Medicine)
Year: 2025

Title: Effect of renal denervation on atrial neural and structural remodeling in rats with obesity-related atrial fibrillation and its mechanism
Authors: Jian, Yi; Sang, Wanyue; Wang, Lu; …; Zhang, Xing; Li, Yaodong
Journal: Chinese Journal of Pathophysiology
Year: 2024

Title: Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study
Authors: Han, Yafan; Shao, Mingliang; Yang, Hang; …; Tang, Baopeng; Li, Yaodong
Journal: Scientific Reports
Year: 2024

Title: A case of endocardial dissection caused by Micra implantation
Authors: Zhang, Jianghua; Shang, Shuai; Dong, Zhenyu; …; Xiaokereti, Jiasuoer; Tang, Baopeng
Journal: BMC Cardiovascular Disorders
Year: 2024

Title: Strategy Optimization for a Combined Procedure in Patients With Atrial Fibrillation: The COMBINATION Randomized Clinical Trial
Authors: Du, Xianfeng; Chu, Huimin; Yang, Bing; …; Yu, Xinzhi; Chen, Xiaomin
Journal: JAMA Network Open
Year: 2024

Title: CALCOCO2 prevents AngII-induced atrial remodeling by regulating the interaction between mitophagy and mitochondrial stress
Authors: Sang, Wanyue; Yan, Xiaoji; Wang, Lu; …; Tang, Baopeng; Li, Yaodong
Journal: International Immunopharmacology
Year: 2024

Songyun Wang | Arrhythmia | Best Researcher Award

Dr. Songyun Wang | Arrhythmia | Best Researcher Award